skip to Main Content

Pop Test & Palisades Therapeutics Companies

Wellness ScreeningWELLNESS Screening/Monitoring

Diabetes

Diagnosed and undiagnosed diabetes in the United States, all ages, 2012, Total: 29.1 million people or 9.3% of the population have diabetes. Diagnosed: 21.0 million people. Undiagnosed: 8.1 million people. (27.8% of people with diabetes are undiagnosed)

NASH/NAFLD

Prevalence of NAFLD and NASH is higher than estimated previously. Hispanics and patients with diabetes are at greatest risk for both NAFLD and NASH. Up to 80% of obese people have the disease. Non-alcoholic steatohepatitis (NASH) is the most extreme form of NAFLD, and is regarded as a major cause of cirrhosis of the liver of unknown cause. About 12 to 25% of people in the United States has NAFLD. While NASH affects between 2 to 5% of people in the United States.

Cholesterol

Percent of adults age 20 years and over with high serum total cholesterol (greater than or equal to 240 mg/dL): 13.4% (2009-2012)

Gout

Gout prevalence swells in U.S. over last two decades; Increase in obesity and hypertension are likely contributors. Prevalence of gout in the United States has risen over the last twenty years and now affects 8.3 million Americans.

For more details about technology: Click here

Compound for Pancreatic Cancer

CancerThe novel compound focuses on inhibiting tumor growth and synergy with chemo in select cancers by targeting Pancreatic Cancer Stem Cells (PanCSCs), which could be an ideal therapy to overcome chemoresistance. The compound tends to be a cutting edge science focused on large critical disease markets. This anti cancer compound invented by Dr. Gurdial Singh has the potential to be a life saving therapy for aggressive cancers.

For more details about technology: Click here

Broad Spectrum Antiviral Polysaccharide_Microbial Technology

Technology relates to a Broad-Spectrum Antiviral Polysaccharides from the marine, heterotrophic, microalgae called thraustochytrids, these microalgae also produce the omega-3 fatty acid, DHA. Therefore, this is an economical process to produce two valuable compounds from safe microorganisms. Proposed Technology addresses following Viruses: Enterovirus, Retrovirus, Cytomegalovirus, Adenovirus, Herpes simplex virus.

For more details about technology: Click here

Novel Terpenoidal Based Analogue Of Vasicine With Multiple Therapeutic Activities

Invention relates to the novel compound of formula I and pharmaceutically acceptable salts thereof and use of the said novel compound for the treatment of asthma. The invention involves design, synthesis and biological evaluation of a novel terpenoid based compound and pharmaceutical acceptable salts thereof which possess multiple therapeutic effects like bronchodilatory, anti- allergic and anti-tussive effects.

For more details about technology: Click here

Preparation Process For Protease Inhibitor Intermediates

Invention relates to Preparation Process of racemic 6, 6-dimethyl-3-azabicyclo-[3.1.0]-hexane, a key raw material for the preparation of key intermediate (1R, 2S, 5S) – methyl 6,6-dimethyl -3-azabicyclo [3.1.0] hexane-2 carboxylic acid for the class of inhibitors of Protease such as Boceprevir. The process is efficient and economic as in this preparation process lithium aluminium hydride is not used.

For more details about technology: Click here

Nutritional Supplements From Green Leafy Vegetables

Technology relates to a Nutritional Supplements from Green Leafy Vegetables to source all nutritional requirements through normal daily food intake. The products have key ingredients such as beta carotene, xanthophylls, chlorophylls, alpha tocopherol among others from green vegetables and the products are used for relief from stress, acidity, nausea, for weight management and also have health benefits for patients suffering from trauma and other health related issues.
For more details about technology: Click here

Back To Top